Clinical Trial

EMBRACE - From Vulnerable to Empowered: Implementation and Evaluation of a Multicomponent Program to Tackling Age-related Decline

Study acronym: EMBRACE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
EMBRACE is a randomized, controlled, multi-domain, blinded clinical trial involving 120 community-dwelling older adults at risk of cognitive decline, lasting 12 months. Participants are randomized 1:1 to either a multicomponent intervention group, including cognitive and language training, physical activity, nutritional counseling with oral health support, and financial and digital literacy education, or to a control group receiving regular health counseling. The trial evaluates the effects of the intervention on cognitive performance, quality of life, functionality, financial literacy, digital inclusion, and other health-related outcomes.
Trial Details
NCT Number NCT07628686
Lead Sponsor University Fernando Pessoa
Conditions Age-Related Cognitive Decline
Enrollment 120 participants
Start Date 2026-06-01
Primary Completion 2028-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-05